Advanced GroHair & GloSkin Clinic Expands Beyond 200+ Clinics with the Grand Launch in SBR Ahmedabad

The inauguration of our SBR Ahmedabad branch marks yet another historic milestone in our journey, as we proudly expand to over 200+ clinics across India and globally. This achievement is not just a number, but a symbol of hope and transformation for those seeking world-class hair regrowth and skin rejuvenation solutions. Backed by the trust…

Read More

Free Medical Camp In Jamnagar, Supported 1500 Patients

JAMNAGAR: At a time when Gujarat’s government is pushing to address healthcare access gaps through its Mukhyamantri Amrutum (MA) Yojana and the state-wide Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) scheme, community-led efforts are amplifying that mission at the grassroots level. The Dawoodi Bohra community successfully conducted a five-day free medical camp at Saifee Maternity…

Read More

A New Ray of Hope for Cancer Patients in Ahmedabad: Launch of State-of-the-Art Radiation Therapy and PET Scan Center at GCS Hospital

GCS Medical College, Hospital, and Research Centre, located in the eastern part of Ahmedabad, has announced the city’s most advanced destination for cancer treatment. According to GCS Hospital COO Dr. JagdishKhoyani and Radiation Oncologist Dr. ChinmaykumarPrajapati, GCS Hospital has now become the only private medical college in Ahmedabad to house PET-CT scan and advanced radiation…

Read More

How Awareness and Technology Are Saving Lives: Advancements in Brain Tumor Care

Rajkot, 18/02/2026: Brain tumors, though less common than other forms of cancer, remain among the most complex medical conditions to treat. They can affect individuals of any age and may present symptoms that are often overlooked or misdiagnosed. Medical experts continue to stress that early diagnosis and timely treatment are key to improving survival rates…

Read More

How Awareness and Technology Are Saving Lives: Advancements in Brain Tumor Care

Rajkot :- Brain tumors, though less common than other forms of cancer, remain among the most complex medical conditions to treat. They can affect individuals of any age and may present symptoms that are often overlooked or misdiagnosed. Medical experts continue to stress that early diagnosis and timely treatment are key to improving survival rates…

Read More

BROTHER’S LIFE-SAVING LIVER DONATION GIVES SISTER A NEW LEASE ON LIFE AT FORTIS MULUND THIS RAKSHA BANDHAN

– Brother donates part of his Liver to save younger sister from advanced Wilson’s Disease, giving her a new lease on life; sibling discharged to return home ahead of Raksha Bandhan Mumbai/Gujarat, August 9, 2025: In a touching gesture of brotherly love, Anas, a 32-year-old man from Palanpur, Gujarat, donated a part of his liver…

Read More

Colgate’s Oral Health Movement – 4.5 Million Screened, Interesting Insights Uncovered,  Drives Dental Visits Across India

New Delhi, 23 June 2025: Colgate-Palmolive (India) Limited has been on a mission to revolutionize India’s Oral Care for over eight decades, with a deep commitment to improving the nation’s Oral Health. While almost 100% of households in India are using toothpaste, the adoption of optimal Oral Care behaviour continues to present an opportunity. While…

Read More

CAPHRA Warns WHO’s Anti-Harm Reduction Shift Disproportionately Hurts India: A Crisis of Sovereignty, Livelihoods, and Public Health Equity

India, 2025: The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has issued a strong warning that the World Health Organization’s (WHO) recent policy shift against tobacco harm reduction not only contradicts decades of evidence but disproportionately harms countries like India—where the consequences are far more complex and far-reaching than in high-income settings. India,…

Read More

Servier India introduces‘Ivosidenib’ (Tibsovo®),in India, First-in-classTargetedTherapy in Oncologyfor Rare IDH1-Mutated AML and Cholangiocarcinoma

2025-Servier India, a subsidiary of the leading French pharmaceutical Servier Group,  announced the launch ofIvosidenib (Tibsovo®), an oral targeted therapy approved in the management of cancer patients with Acute Myeloid Leukemia (AML) and Cholangiocarcinoma,with an isocitrate dehydrogenase-1 (IDH1) mutation. Servier India received the approval on 14th May 2025, from Central Drugs Standard Control Organisation (CDSCO)…

Read More